重酒石酸长春瑞滨,CAS 登记号 125317-39-7,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 重酒石酸长春瑞滨 的 CAS 号:125317-39-7,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Vinorelbine Bitartrate · CAS 125317-39-7 · C53H66N4O20. UNII 253GQW851Q.
| CAS Registry Number | 125317-39-7 |
|---|---|
| PubChem CID | 11607738 |
| Molecular formula | C53H66N4O20 |
| UNII (FDA) | 253GQW851Q |
| Molecular Weight | 1079.1 |
|---|---|
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 23 |
| Rotatable Bond Count | 16 |
| Exact Mass | 1078.42704051 |
| Monoisotopic Mass | 1078.42704051 |
| Topological Polar Surface Area | 364 |
| Heavy Atom Count | 77 |
| Formal Charge | 0 |
| Complexity | 1820 |
| Reported hazard statements | H301 (88.9%), H315 (96.8%), H319 (96.8%), H341 (95.2%), H360 (95.2%), H372 (90.5%) |
|---|
H301 (88.9%): Toxic if swallowed [Danger Acute toxicity, oral]
H315 (96.8%): Causes skin irritation [Warning Skin corrosion/irritation]
Vinorelbine tartrate; Vinorelbine ditartrate; KW-2307; Vinorelbine liposomal; 253GQW851Q; Vinorelbine (as tartrate); Vinorelbine Bitartrate; Liposomal vinorelbine tartrate; Vinorelbine tartrate (1:2); TLC178; TLC-178; Eunades; DTXSID5047825; Nor-5'-anhydrovinblastine ditartrate; C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:2) (salt); Vinorelbine Ditartarate
CAS 125317-39-7; molecular formula C53H66N4O20; molecular weight — g/mol.
Vinorelbine tartrate, Vinorelbine ditartrate, KW-2307, Vinorelbine liposomal, 253GQW851Q, Vinorelbine (as tartrate).
Hazard statements reported: H301, H315, H319, H341, H360.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.